HomeQuestion

What degree of treatment related hypocalcemia would you tolerate with denosumab before switching agents?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Would you use a parathyroid hormone analog for treatment of osteoporosis in a patient with mildly elevated AlkPhos of unclear etiology?

When transitioning from romosozumab to alendronate or teriparatide to alendronate, is there a minimum amount of time that alendronate needs to be continued to prevent loss of BMD gains?

How do you approach the diagnostic evaluation of osteoporosis in CKD when renal dysfunction limits use of certain tests or biomarkers?

What is the recommended timing for starting denosumab after completing zoledronic acid?

Would you consider a shorter course of Romosozumab (3 months) followed by maintenance therapy given recent evidence that it is noninferior to 12 months of therapy for treatment of severe osteoporosis?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.